- Credit Suisse 29th Annual
Virtual Healthcare Conference . MacroGenics’ management will participate in one-on-one meetings and provide a corporate overview on November 10, 2020 at2:45 PM ET . - Stifel 2020
Virtual Healthcare Conference . MacroGenics’ management will participate in one-on-one meetings and participate in a fireside chat with the analyst on November 17, 2020 at10:40 AM ET . - SVB Leerink Oncology 1x1 Day. MacroGenics’ management will participate in one-on-one meetings on
November 19, 2020 . Evercore ISI 3rd AnnualHealthCONx Virtual Conference . MacroGenics’ management will participate in one-on-one meetings and participate in a fireside chat with the analyst on December 2, 2020 at3:55 PM ET .
Webcasts of the above presentations may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain archived replays of these webcasts on its website for 30 days after each conference.
About MacroGenics, Inc.
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. For more information, please see the Company's website at www.macrogenics.com. MacroGenics and the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.
###
Jim Karrels , Senior Vice President,CFO MacroGenics, Inc. 1-301-251-5172, info@macrogenics.com
Source: MacroGenics, Inc.